Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Omega-3 Fatty Acids for the Reduction of Hyperactivity in Children With Autism Spectrum Disorder

NCT01694667 is registered in ClinicalTrials.gov with Hugo W. Moser Research Institute at Kennedy Krieger, Inc. as lead sponsor.

NCT NCT01694667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01694667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Omega-3 Fatty Acids for the Reduction of Hyperactivity in Children With Autism Spectrum Disorder
Lead sponsor
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2012
Completion date
May 31, 2013
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorders, hyperactivity